This week, the White House granted President Biden the greenlight to move forward with removing a Trump-era health care policy designed to lower the price of insulin.
Biden's bid to retract the rule was reported on Monday, as reported by Politico with the expectation that the Department of Health and Human Services could publish the retraction within the coming days.
The measure, signed off under the new administration in December, aimed to bring down some 340 B community health centers to provide savings to low-income patients for insulin and epinephrine in order to make it more affordable.
Spokespeople for the White House and the Department of Health and Human Services did not return FOX Business' request for comment.
The rule was originally set to go into effect in January but was frozen at that time.
Earlier this year, the National Association of Health Care Centers said the new rule would adversely affect Community Health Centers and make it harder for the low-income patients to afford the medications themselves.
He has focused on improving drug prices during his tenure by lowering the president's presidency. Biden has made similar promises, including calls for allowing Medicare to negotiate lower prices for prescription drugs.